The role of radiotherapy in urinary bladder cancer: current status (Q38007290)

26 August 2017

title

The role of radiotherapy in urinary bladder cancer: current status (English)

1 reference

adaptive radiation therapy

26 August 2017

main subject

0 references

1 reference

Samir Abdallah Hanna

2

0 references

author name string

Gustavo Nader Marta

1

1 reference

26 August 2017

Rafael Gadia

3

1 reference

26 August 2017

Sebastiao Francisco Miranda Correa

4

1 reference

26 August 2017

Joao Luis Fernandes da Silva

5

1 reference

26 August 2017

Heloisa de Andrade Carvalho

6

1 reference

26 August 2017

publication date

1 March 2012

1 reference

International Brazilian Journal of Urology

26 August 2017

published in

1 reference

26 August 2017

volume

38

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

144-53; discussion 153-4

1 reference

26 August 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Urothelial dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Radiation therapy before cystectomy in the management of patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Bladder cancer.Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Treatment results of radiation therapy for muscle-invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Optimal management of the T1G3 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Radiotherapy in localized bladder cancer: what is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1677-55382012000200002

10.1590/S1677-55382012000200002

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference